search
Back to results

Empowered Relief Delivered by Nurses (ERA)

Primary Purpose

Pain, Chronic

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Empowered Relief
Sponsored by
Washington State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Chronic focused on measuring Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: age > 18 years pain >3 months more than half the time English fluency ability to attend a one-time web-based class and complete web-based surveys. Exclusion criteria: Previous participation in ER class cognitive impairment non-English speaking psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Other

    Arm Label

    Empowered Relief treatment

    Wait-list Control

    Arm Description

    Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

    Participants randomized to the Wait-list Control group will continue their usual pain care for 2 months and complete surveys to compare with the experimental treatment group. After serving as controls, they will be invited to attend the 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

    Outcomes

    Primary Outcome Measures

    Change in Pain Catastrophizing
    Measured by self-report

    Secondary Outcome Measures

    Change in Pain Intensity
    0-10 Pain severity scale

    Full Information

    First Posted
    June 17, 2023
    Last Updated
    June 27, 2023
    Sponsor
    Washington State University
    Collaborators
    American Society for Pain Management Nursing
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05934435
    Brief Title
    Empowered Relief Delivered by Nurses
    Acronym
    ERA
    Official Title
    Addressing Pain Care Inequities With Empowered Relief Delivered by ASPMN Nurses: A Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    August 1, 2023 (Anticipated)
    Primary Completion Date
    August 1, 2024 (Anticipated)
    Study Completion Date
    October 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Washington State University
    Collaborators
    American Society for Pain Management Nursing

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study will investigate effects of a psychoeducation pain management skills intervention on adults with persistent pain by training a cohort of American Society for Pain Management Nursing (ASPMN) nurses to deliver and it [Empowered Relief (ER)], as a single-session video-conferenced program. The primary objective is to evaluate the effects of ASPMN nurse-provided ER versus waitlist control (WLC) on pain catastrophizing, pain bothersomeness, pain intensity, pain interference, sleep disturbance, physical function, depression, anxiety, and social isolation for patients with persistent pain. Secondarily, feasibility and acceptability of the ER program will be assessed through recruitment and retention data and qualitative satisfaction data.
    Detailed Description
    Design: This study will be conducted as a randomized controlled trial comparing effects of ER to a WLC of participants with persistent pain when ER is provided by ER-trained ASPMN nurses. The secondary aims of feasibility and acceptability will use qualitative descriptive methods. Participants: Participants (N=170) will be adults aged 18 and above years with self- reported or clinically diagnosed persistent pain. Participants will be recruited at clinical sites identified by ER-trained nurses and can be self or clinician referred. Participants will complete an online eligibility form to screen for inclusion and exclusion criteria. Inclusion criteria: pain >3 months more than half the time, English fluency, ability to attend a one-time web-based class and complete web-based surveys, age > 18 years. Exclusion criteria: Previous participation in ER class, cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators. Procedures: Twenty ASPMN nurses will receive ER training facilitated by Stanford Pain Relief Innovations Lab. ER- trained nurse providers will be ASPMN-member nurses of any clinical background. ASPMN nurses will be invited to apply to become a trainer with the following expectations: ability to fully participate in a live, online, 2-day ER instructor training, able to fluently complete instructor training and deliver the ER program in English, commitment to deliver 1-3 live, online, 2-hour ER programs for patient participants, and willingness to complete post-program surveys after each session they deliver reporting on number of participants and any barriers encountered. Recruitment will occur through ASPMN-related mechanisms of communication, including its website, national officers and directors, newsletter, research group, national committees, chapter leadership and listserv. After meeting eligibility criteria and completing informed consent, study participants will be asked to complete a baseline survey of demographics and health variables (as outlined in Table 1) and then randomized 1:1 to one of two unblinded study groups: ER and WLC. Participants randomized to the ER group will complete a HIPAA compliant, password protected Zoom ER class delivered by an ER-trained ASPMN nurse. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Chronic
    Keywords
    Pain

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    After randomized 1:1 to one of two unblinded study groups: ER and Wait-List Control, participants randomized to the ER group will complete the ER class. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.
    Masking
    Outcomes Assessor
    Masking Description
    Biostatistician will be blinded to ER treatment group or Wait-list Control group.
    Allocation
    Randomized
    Enrollment
    170 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Empowered Relief treatment
    Arm Type
    Experimental
    Arm Description
    Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.
    Arm Title
    Wait-list Control
    Arm Type
    Other
    Arm Description
    Participants randomized to the Wait-list Control group will continue their usual pain care for 2 months and complete surveys to compare with the experimental treatment group. After serving as controls, they will be invited to attend the 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.
    Intervention Type
    Other
    Intervention Name(s)
    Empowered Relief
    Other Intervention Name(s)
    ER
    Intervention Description
    psycho-educational pain skills training
    Primary Outcome Measure Information:
    Title
    Change in Pain Catastrophizing
    Description
    Measured by self-report
    Time Frame
    Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.
    Secondary Outcome Measure Information:
    Title
    Change in Pain Intensity
    Description
    0-10 Pain severity scale
    Time Frame
    Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: age > 18 years pain >3 months more than half the time English fluency ability to attend a one-time web-based class and complete web-based surveys. Exclusion criteria: Previous participation in ER class cognitive impairment non-English speaking psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Holly Watson, MSN
    Phone
    614-204-4929
    Email
    holly409@icloud.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Marian Wilson, PhD
    Organizational Affiliation
    Washington State University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    Can be requested from principal investigator
    IPD Sharing Time Frame
    After publication
    IPD Sharing Access Criteria
    Use for secondary analysis

    Learn more about this trial

    Empowered Relief Delivered by Nurses

    We'll reach out to this number within 24 hrs